Nektar Therapeutics

NASDAQ: NKTR
$1.10
+$0.09 (+8.4%)
Real Time Data Delayed 15 Min.

NKTR Stock Chart and Intraday Price

NKTR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 148.80M USD
Shares Outstanding 190,771,000
Nektar Therapeutics is a biopharmaceutical firm based in San Francisco, focusing on creating innovative medicines in immunotherapy. The company is working on treatments for a range of conditions, including systemic lupus erythematosus, ulcerative colitis, atopic dermatitis, psoriasis, non-Hodgkin’s lymphoma, multiple myeloma, and various cancers. With a strong commitment to advancing healthcare, Nektar Therapeutics collaborates with leading pharmaceutical companies worldwide to bring new therapies to patients in need.

NKTR Articles

Thursday's Top Analyst Upgrades and Downgrades: Airbnb, Antero Midstream, Exact Sciences, GitLab, Lumentum, Nektar Therapeutics, PayPal and More
Thursday's top analyst upgrades and downgrades included Airbnb, Alcon, Antero Midstream, Exact Sciences, GitLab, GlobalFoundries, Halozyme Therapeutics, Lumentum, Nektar Therapeutics, PayPal and...
Lee Jackson
Published:

More Inflation Ahead? Analysts Upgrade or Downgrade Coinbase, Grab, Roku and More
Monday's additional top analyst upgrades and downgrades were on Coinbase Global, Global Blood Therapeutics, Grab, Leslie’s, Nektar Therapeutics, Park Hotels & Resorts, Rocket Companies and Roku.
Chris Lange
Published:

The Case for a Bear Market Rally: Analysts Upgrade or Downgrade Dow, Rocket Companies, Zoom Video and More
Tuesday’s additional top analyst upgrades and downgrades included Dow, Estee Lauder, Magellan Midstream Partners, Nektar Therapeutics, Novo Nordisk, Rocket Companies, Sherwin-Williams, Steel...
Chris Lange
Published:

Is Earnings Optimism Enough? Analyst Upgrades and Downgrades: CSX, Gap, Peloton, United Airlines and More
Monday’s additional top analyst upgrades and downgrades included Aptiv, BioCryst Pharmaceuticals, CSX, Gap, Nektar Therapeutics, Progressive, Peloton Interactive, Sirius XM and United Airlines.
Chris Lange
Published:

More Tuesday Analyst Upgrades and Downgrades: With Fed Rate Hike Coming, Analysts Target GoodRx, Mosaic, Nektar Therapeutics and More
Tuesday afternoon's top analyst upgrades and downgrades included Coupa Software, GoodRx, Mosaic and Nektar Therapeutics.
Chris Lange
Published:

Wednesday Afternoon's Top Analyst Upgrades and Downgrades: Coupang, Foot Locker, Gap, Stitch Fix and More
Wednesday afternoon's top analyst upgrades and downgrades included Bumble, Coupang, Foot Locker, Gap, Match, Nektar Therapeutics, Paychex, Signify Health and Stitch Fix.
Chris Lange
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Bloomin' Brands, Bumble, Goldman Sachs, Juniper Networks, Merck, Moderna, Spirit Airlines, Wells Fargo and More
Tuesday’s top analyst upgrades and downgrades included Bloomin' Brands, Boston Beer, Bumble, Goldman Sachs, Juniper Networks, Merck, Moderna, Petco Health, Southern Company, Spirit Airlines and...
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Airbnb, Canopy Growth, Continental Resources, DraftKings, Fisker, Moderna, SunPower and More
Tuesday's top analyst upgrades and downgrades included Airbnb, Canopy Growth, Continental Resources, DraftKings, Fisker, Moderna, Owens Corning, SunPower and Wayfair.
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: American Tower, Best Buy, Beyond Meat, Freeport McMoRan, First Solar, UnitedHealth and More
Friday’s top analyst upgrades and downgrades included American Tower, Best Buy, Beyond Meat, Editas Medicine, Freeport McMoRan, First Solar and UnitedHealth.
Chris Lange
Published:

Monday's Top Analyst Upgrades and Downgrades: GoDaddy, Groupon, ResMed, Salesforce, Shopify, Squarespace, Yelp and More
Monday’s top analyst upgrades and downgrades included GoDaddy, Groupon, Resmed, Salesforce, Shopify, Squarespace, Yelp, and more.
Chris Lange
Published:

BioNTech, Exelixis, Foot Locker and More Tuesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More
Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and ViacomCBS.
Jon C. Ogg
Published:

Top Analyst Upgrades and Downgrades: Altria, Beyond Meat, Chevron, Chipotle, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm, Target and More
Wednesday's top analyst upgrades, downgrades and initiations included Altria, Beyond Meat, Chevron, Chipotle Mexican Grill, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm and...
Jon C. Ogg
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
Jon C. Ogg
Published:

This Week's Biggest Biotech Movers
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
Chris Lange
Published: